Free Trial!
Today’s Best Stocks To Trade! Click Here
Reddy Ice Holdings Inc. (NYSE: FRZ | Quote | Chart | News | PowerRating) engages in the manufacture and distribution of packaged ice under the brand name Reddy Ice' in the United States. It produces ice in cube, half-moon, cylindrical, crushed, and block forms. The company markets its products to supermarket chains, mass merchants, convenience stores, wholesale ice and food distributors, commercial users, resorts and restaurants, agricultural buyers, and competitive producers and self-suppliers. Reddy Ice Holdings serves approximately 82,000 locations in 31 states and the District of Columbia. The company is headquartered in Dallas, Texas. With 22 million shares outstanding and 1.94 million shares declared short as of May 2008, there is a failure to deliver in shares of FRZ. According to quarterly data provided by the SEC, there were still 22,680 shares of FRZ that were failing-to-deliver as of August 22, 2007.
Mahanagar Telephone Nigam Ltd. (NYSE: MTE | Quote | Chart | News | PowerRating) provides fixed-line and other basic telecommunications services in Delhi and Mumbai, India. It offers basic fixed-line access; public call offices; global system for mobile communications(GSM) cellular services, such as call-waiting, call-forwarding, wake-up calls, absent subscriber service and caller identification, night talk, VMS call conference, and wireless application protocol and voice mail; and phone plus facilities in basic fixed-line, such as abbreviated dialing, call transfer, hotline facility, three party conferencing, absentee facility, CLIP facility, call hunting, call alert, and morning alarm. The company also offers mobile and fixed-wireless services based on CDMA technology; high speed data transmission; data communications services; Internet access services; leased line services; telex and intelligent network services; and interconnection with domestic international long distance carriers and with basic and cellular operators. As of March 31, 2007, MTNL had approximately 2,012,343 GSM cellular subscribers; 1.29 million Internet access subscribers; and 118,648 operational CDMA mobile subscribers and 79,573 operational fixed wireless subscribers. The company was founded in 1986 and is based in New Delhi, India. With 315 million shares outstanding and 878,800 shares declared short as of May 2008, there is a failure to deliver in shares of MTE. According to quarterly data provided by the SEC, there were still 66,096 shares of MTE that were failing-to-deliver as of September 28, 2007.
EnerNOC Inc. (NASDAQ: ENOC | Quote | Chart | News | PowerRating) provides demand response and energy management solutions to commercial, institutional, and industrial customers, as well as electric power grid operators and utilities in the United States. Its solutions enable in optimizing the balance of electric supply and demand. The company offers reliability-based demand response; price-based demand response that enables customers to monitor and respond to wholesale electricity market price signals; and ancillary services. EnerNOC also offers meter data gathering and storage services for advanced meters; energy analytics and control services; and energy procurement services. As of December 31, 2007, it had approximately 2,189 customer sites and 1,112 megawatts of demand response capacity under management. The company was founded in 2001. It was formerly known as EnerNOC, LLC and changed its name to EnerNOC, Inc. in 2003. EnerNOC is headquartered in Boston, Massachusetts. With 19.73 million shares outstanding and 1.62 million shares declared short as of May 2008, there is a failure to deliver in shares of ENOC. According to quarterly data provided by the SEC, there were still 22,570 shares of ENOC that were failing-to-deliver as of August 20, 2007.
Esmark Inc. (NASDAQ: ESMK | Quote | Chart | News | PowerRating) through its subsidiaries, engages in the manufacture, processing, and sale of steel products. It operates in two segments, Downstream Operations and Mill Operations. The Downstream Operations segment processes and distributes flat-rolled steel products, including hot-rolled, cold-rolled, hot-dipped galvanized, electro-galvanized, and pre-painted steel products to customers in the construction, automotive, appliance, shelving, and agricultural markets in the Midwestern portion of the United States. The Mill Operations segment produces flat-rolled steel products, including hot-rolled, cold-rolled, galvanized, pre-painted, and tin mill sheet steel products. It also manufactures fabricated steel products, including roll-formed corrugated roofing, roof deck, form deck, floor deck, bridgeform, and other products. This segment sells its products to converters and processors, and steel service centers, as well as to customers in the construction, agriculture, highway, and container markets located in the United States. The company was founded in 2003 and is headquartered in Wheeling, West Virginia. With 39.51 million shares outstanding and 1.44 million shares declared short as of May 2008, there is a failure to deliver in shares of ESMK.
MEDecision Inc. (NASDAQ: MEDE | Quote | Chart | News | PowerRating) together with its subsidiaries, provides collaborative health care management solutions, including integrated software, services, and clinical content to health care payers in the United States. Its collaborative health care management solutions include Alineo, a platform addressing case management, disease management, and utilization management within a payer organization; and Nexalign, a collaborative health information exchange service. The Alineo solution provides intuitive predictive modeling tools to identify patients who can immediately benefit from case and disease management programs; delivers turnkey clinical knowledge and pathways based on embedded clinical content; and allows payers to administer and evaluate member and population-wide health care programs, including approvals, referrals, and extensions. Its Nexalign solution provides a solution for health care payers, patients, physicians, and other health care providers to securely access and exchange health information for clinical decisions. Nexalign is designed around Clinical Summaries, which are payer-based electronic health records that have been clinically validated. In addition, the company develops MEDeWeaver, a technology that gathers patient data stored in several different databases, and analyzes this data for inconsistencies and combines them into one report. MEDecision licenses its solutions to managed care organizations and health insurance companies primarily through its direct sales force. The company also offers professional services, including implementation, consulting, and training. MEDecision was incorporated in 1988 and is headquartered in Wayne, Pennsylvania. With 16.29 million shares outstanding and 8,300 shares declared short as of May 2008, there is a failure to deliver in shares of MEDE. According to quarterly data provided by the SEC, there were still 48,678 shares of MEDE that were failing-to-deliver as of September 28, 2007.
SGX Pharmaceuticals Inc. (NASDAQ: SGXP | Quote | Chart | News | PowerRating) a biotechnology company, focuses on the discovery, development, and commercialization of therapeutics for addressing unmet medical needs in oncology. The company's product pipeline includes drug candidates from its FAST drug discovery platform, which uses X-ray crystallography and complementary biophysical and biochemical methods, combined with medicinal and computational chemistry. Its drug development programs target the c-MET receptor tyrosine kinase (MET), an enzyme implicated in an array of cancers; and the BCR-ABL tyrosine kinase enzyme for the treatment of chronic myelogenous leukemia (CML), a bone marrow cancer. Under the MET development program, the company develops SGX523, which is in Phase I clinical development studies for solid tumor indications; and SGX126, a preclinical development product for solid tumors indications. Under the BCR-ABL Development Program, SGX Pharmaceuticals develops SGX393, an oral therapy for the second-line treatment of CML, which is in preclinical development studies. Its drug discovery technologies are also applied to a portfolio of oncology targets, including JAK2, a non-receptor tyrosine kinase involved in cytokine-induced signaling and growth regulation, survival, and differentiation of cells; RAS, a protein that regulates cell growth; and three other tyrosine kinases. The company has a license and collaboration agreement with Novartis Institutes for Biomedical Research, Inc., Cystic Fibrosis Foundation Therapeutics, Inc., National Institutes of Health, and Eli Lilly & Company. SGX Pharmaceuticals, formerly known as Structural GenomiX, Inc., was founded in 1998 and is headquartered in San Diego, California. With 20.51 million shares outstanding and 10,600 shares declared short as of May 2008, there is a failure to deliver in shares of SGXP.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,000,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
